Griffiths Richard Ian → Silence Therapeutics plc SLNCF

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 10/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

136 shares short · -94.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $694K

Point72 Asset Mgmt

Other 13D/G Filings on Silence Therapeutics plc

Filed	Form	Filer	Stake	Shares
2026-10-13	SCHEDULE 13G	Tetragon Financial Management LP	—	—	view →
2026-08-13	SCHEDULE 13D/A	Griffiths Richard Ian	—	14,391,498	view →
2026-07-08	SCHEDULE 13D/A	Griffiths Richard Ian	21.70%	30,844,458	view →
2023-08-14	SC	Griffiths Richard Ian	—	—	view →

Other Filings by Griffiths Richard Ian

Filed	Form	Issuer	Stake	Shares
2026-08-13	SCHEDULE 13D/A	Silence Therapeutics Plc	—	14,391,498	view →
2026-07-08	SCHEDULE 13D/A	Silence Therapeutics Plc SLNCF	21.70%	30,844,458	view →
2023-08-14	SC	Silence Therapeutics plc SLNCF	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →